raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:293964

Hypoinsulinemic hypoglycemia and body hemihypertrophy

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Infancy, Neonatal
Status
active

Hypoinsulinemic hypoglycemia and body hemihypertrophy is a rare, genetic, endocrine disease characterized by neonatal macrosomia, asymmetrical overgrowth (typically manifesting as left-sided hemihypertrophy) and recurrent, severe hypoinsulinemic (or hypoketotic hypo-fatty-acidemic) hypoglycemia in infancy, which results in episodes of reduced consciousness and seizures.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHypoinsulinemic hypoglycemia and body hemihypertrophy
frHypoglycémie hypoinsulinémique avec hémihypertrophie du corps
deHypoinsulinämische Hypoglykämie - Hemihypertrophie
esHipoglucemia hipoinsulinémica y hemihipertrofia corporal
itIpoglicemia ipoinsulinemica ed emi-ipertrofia del corpo
nlHypo-insulinemische hypoglycemie en hemihypertrofie van lichaam
ptHipoglicemia hipoinsulinémica e hemihipertrofia corporal
plHipoglikemia hipoinsulinemiczna i połowiczy przerost ciała
csHypoinzulinemická hypoglykémie a hemihypertrofie těla
ukГіпоінсулінемічна гіпоглікемія та гемігіпертрофія тіла
zh低胰岛素型低血糖和偏身肥大
trHipoinsülinemik hipoglisemi ve vücut hemihipertrofisi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM240900Evalidated
ICD-10E16.8NTBTattributedvalidated
ICD-115A4YNTBTattributedvalidated
MONDO0009416Evalidated
UMLSC4751124Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
AKT2Disease-causing germline mutation(s) (gain of function) inAssessedHGNC:392ENSG0000010522116473119q13.2AKT serine/threonine kinase 221979934[PMID]_24285683[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families5 casesWorldwideCase(s)Validated14764948[PMID]_21979934[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

14 annotations · validated 2017-04-26
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0001528Hemihypertrophy
Very frequent (99-80%)
HP:0040214Abnormal circulating insulin concentration
HP:0030812Enlarged tonsils
HP:0000771Gynecomastia
HP:0001325Hypoglycemic coma
HP:0002173Hypoglycemic seizures
HP:0001985Hypoketotic hypoglycemia
HP:0006568Increased hepatic glycogen content
HP:0001520Large for gestational age
HP:0001998Neonatal hypoglycemia
HP:0001958Nonketotic hypoglycemia
HP:0001956Truncal obesity
Excluded (0%)
HP:0002960Autoimmunity
HP:0030781Increased circulating free fatty acid level

Run the differential on the 12 obligate / very frequent terms

Annotation source: 21979934[PMID]_13952653[PMID]_14764948[PMID]

7

Sources for this card